AIG
CTKB icon

American International Group’s Cytek Biosciences CTKB Stock Holding History

American International Group’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-64,321
Closed -$432K – 665
2024
Q1 		$432K Sell
64,321
-570
-0.9% -$4.51K ﹤0.01% 1736
2023
Q4 		$592K Sell
64,891
-524
-0.8% -$3.3K ﹤0.01% 1572
2023
Q3 		$361K Buy
65,415
+2,628
+4% +$21.1K ﹤0.01% 1790
2023
Q2 		$536K Buy
62,787
+7,676
+14% +$68.8K ﹤0.01% 1599
2023
Q1 		$506K Buy
55,111
+1,097
+2% +$11.8K ﹤0.01% 1595
2022
Q4 		$551K Sell
54,014
-197
-0.4% -$2.65K ﹤0.01% 1536
2022
Q3 		$798K Buy
54,211
+767
+1% +$9.96K 0.01% 1299
2022
Q2 		$573K Buy
53,444
+5,003
+10% +$49.8K ﹤0.01% 1522
2022
Q1 		$522K Buy
48,441
+39,907
+468% +$539K ﹤0.01% 1696
2021
Q4 		$139K Sell
8,534
-255
-3% -$5.34K ﹤0.01% 2566
2021
Q3 		$188K Buy
+8,789
New +$207K ﹤0.01% 2469

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

American International Group's CTKB Position: Q2 2024 in Review

American International Group sold out of Cytek Biosciences (CTKB) in Q2 2024, closing a stake of 64,321 shares — an estimated $432K sold.

American International Group first reported a position in CTKB in Q3 2021 and held it in 11 quarters. The position peaked at $798K in Q3 2022. 128 funds tracked by Wall St. Rank hold CTKB as of Q2 2024.

  • American International Group reported no remaining Cytek Biosciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 64,321 Cytek Biosciences shares in Q2 2024, an estimated $432K.
  • American International Group first reported a position in Cytek Biosciences in Q3 2021 and held it in 11 quarters.
  • American International Group's Cytek Biosciences position peaked at $798K in Q3 2022.
  • 128 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.